Epigenetic modulation reveals differentiation state specificity of oncogene addiction
出版年份 2021 全文链接
标题
Epigenetic modulation reveals differentiation state specificity of oncogene addiction
作者
关键词
-
出版物
Nature Communications
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-03-09
DOI
10.1038/s41467-021-21784-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Genetic screening for single-cell variability modulators driving therapy resistance
- (2021) Eduardo A. Torre et al. NATURE GENETICS
- Quantitative Proteomics of the Cancer Cell Line Encyclopedia
- (2020) David P. Nusinow et al. CELL
- Charting the Fragmented Landscape of Drug Synergy
- (2020) Christian T. Meyer et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Phenotype-based probabilistic analysis of heterogeneous responses to cancer drugs and their combination efficacy
- (2020) Natacha Comandante-Lou et al. PLoS Computational Biology
- Lineage plasticity in cancer: a shared pathway of therapeutic resistance
- (2020) Álvaro Quintanal-Villalonga et al. Nature Reviews Clinical Oncology
- Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma
- (2020) Jasper Wouters et al. NATURE CELL BIOLOGY
- The Stress-Like Cancer Cell State Is a Consistent Component of Tumorigenesis
- (2020) Maayan Baron et al. Cell Systems
- MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in BRAF-, NRAS-, and NF1-Mutant Melanomas
- (2019) Ophélia Maertens et al. Cancer Discovery
- Tissue-specificity in cancer: The rule, not the exception
- (2019) Kevin M. Haigis et al. SCIENCE
- HDAC8 regulates a stress response pathway in melanoma to mediate escape from BRAF inhibitor therapy
- (2019) Michael F. Emmons et al. CANCER RESEARCH
- Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathways
- (2019) Xue Bai et al. Nature Reviews Clinical Oncology
- The great escape: tumour cell plasticity in resistance to targeted therapy
- (2019) Soufiane Boumahdi et al. NATURE REVIEWS DRUG DISCOVERY
- Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress
- (2018) Jennifer Tsoi et al. CANCER CELL
- Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma
- (2018) Yong Yu et al. CANCER CELL
- Toward Minimal Residual Disease-Directed Therapy in Melanoma
- (2018) Florian Rambow et al. CELL
- LSD1 activates a lethal prostate cancer gene network independently of its demethylase function
- (2018) Archana Sehrawat et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CellProfiler 3.0: Next-generation image processing for biology
- (2018) Claire McQuin et al. PLOS BIOLOGY
- KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance
- (2018) Kunihiko Hinohara et al. CANCER CELL
- KDM5B Promotes Drug Resistance by Regulating Melanoma Propagating Cell Subpopulations
- (2018) Xiaoni Liu et al. MOLECULAR CANCER THERAPEUTICS
- Jumonji Inhibitors Overcome Radioresistance in Cancer through Changes in H3K4 Methylation at Double-Strand Breaks
- (2018) Juan Bayo et al. Cell Reports
- Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene
- (2017) Barbara Fontanals-Cirera et al. MOLECULAR CELL
- Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de‐differentiated state
- (2017) Mohammad Fallahi‐Sichani et al. Molecular Systems Biology
- Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
- (2017) Sydney M. Shaffer et al. NATURE
- Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance
- (2017) Yapeng Su et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
- (2017) Sheng Yu Ku et al. SCIENCE
- Degree of Tissue Differentiation Dictates Susceptibility to BRAF-Driven Colorectal Cancer
- (2017) Kevin Tong et al. Cell Reports
- Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression
- (2017) Petko Fiziev et al. Cell Reports
- Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
- (2016) Michael P. Smith et al. CANCER CELL
- Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
- (2016) Aaron N Hata et al. NATURE MEDICINE
- An unbiased metric of antiproliferative drug effect in vitro
- (2016) Leonard A Harris et al. NATURE METHODS
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
- (2016) I. Tirosh et al. SCIENCE
- Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance
- (2015) Willy Hugo et al. CELL
- Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
- (2015) Douglas B. Johnson et al. EUROPEAN JOURNAL OF CANCER
- Systematic analysis of BRAFV600E melanomas reveals a role for JNK/c-Jun pathway in adaptive resistance to drug-induced apoptosis
- (2015) M. Fallahi-Sichani et al. Molecular Systems Biology
- Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
- (2015) Annelien Verfaillie et al. Nature Communications
- Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
- (2014) Chong Sun et al. NATURE
- A stress-induced early innate response causes multidrug tolerance in melanoma
- (2014) D Ravindran Menon et al. ONCOGENE
- Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
- (2014) Judith Müller et al. Nature Communications
- A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
- (2014) D. J. Konieczkowski et al. Cancer Discovery
- Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
- (2013) Alexander Roesch et al. CANCER CELL
- A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
- (2013) Cory M. Johannessen et al. NATURE
- Tumor adaptation and resistance to RAF inhibitors
- (2013) Piro Lito et al. NATURE MEDICINE
- TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in BRAF-Mutant Melanoma
- (2013) R. B. Corcoran et al. Science Translational Medicine
- A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth
- (2013) Lei Wang et al. Nature Communications
- Modeling Neural Crest Induction, Melanocyte Specification, and Disease-Related Pigmentation Defects in hESCs and Patient-Specific iPSCs
- (2013) Yvonne Mica et al. Cell Reports
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- Oncogenic BRAF Regulates Melanoma Proliferation through the Lineage Specific Factor MITF
- (2008) Claudia Wellbrock et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started